Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mathieu

Showing results (261-270 of 276) with videos related to

Pageof 28
Sort By:
Rheumatology (Oxford, England)|August 30, 2008
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapyI Olivieri, S de Portu, C Salvarani, et al.
Molecular and Biochemical Parasitology|September 12, 2003
Functional expression and characterization of Schistosoma mansoni cathepsin B and its trans-activation by an endogenous asparaginyl endopeptidaseMohammed Sajid, James H McKerrow, Elizabeth Hansell, et al.
Clinical and Experimental Rheumatology|September 19, 2008
Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian studyA Mameli, A Cauli, E Taccari, et al.
Clinical and Experimental Rheumatology|October 21, 1998
Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLEM Galeazzi, G Morozzi, G D Sebastiani, et al.
Scandinavian Journal of Rheumatology|February 9, 2000
Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLEG D Sebastiani, M Galeazzi, A Tincani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patientsN Milpied, B Vasseur, N Parquet, et al.
Medicine|June 3, 1999
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus ErythematosusR Cervera, M A Khamashta, J Font, et al.
Lupus|August 2, 2003
HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosusG D Sebastiani, M Galeazzi, A Tincani, et al.
Blood|January 3, 2001
Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluationP Colombat, G Salles, N Brousse, et al.
Lupus|May 22, 2018
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onsetG D Sebastiani, I Prevete, A Iuliano, et al.
Pageof 28

Showing results (261-270 of 276) with videos related to

Sort By:
Pageof 28
Rheumatology (Oxford, England)|August 30, 2008
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapyI Olivieri, S de Portu, C Salvarani, et al.
Molecular and Biochemical Parasitology|September 12, 2003
Functional expression and characterization of Schistosoma mansoni cathepsin B and its trans-activation by an endogenous asparaginyl endopeptidaseMohammed Sajid, James H McKerrow, Elizabeth Hansell, et al.
Clinical and Experimental Rheumatology|September 19, 2008
Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian studyA Mameli, A Cauli, E Taccari, et al.
Clinical and Experimental Rheumatology|October 21, 1998
Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLEM Galeazzi, G Morozzi, G D Sebastiani, et al.
Scandinavian Journal of Rheumatology|February 9, 2000
Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLEG D Sebastiani, M Galeazzi, A Tincani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patientsN Milpied, B Vasseur, N Parquet, et al.
Medicine|June 3, 1999
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus ErythematosusR Cervera, M A Khamashta, J Font, et al.
Lupus|August 2, 2003
HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosusG D Sebastiani, M Galeazzi, A Tincani, et al.
Blood|January 3, 2001
Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluationP Colombat, G Salles, N Brousse, et al.
Lupus|May 22, 2018
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onsetG D Sebastiani, I Prevete, A Iuliano, et al.
Pageof 28